875 results on '"Raspollini, Maria Rosaria"'
Search Results
202. Postsurgical Necrobiotic Granuloma of Urinary Bladder
203. Hydrocele Testis
204. Cystite Follicularis
205. Urothelial Carcinoma, Sarcomatoid Type
206. Bladder Cloacal Extrophy
207. Urinary Tract Pure Squamous Cell Carcinoma
208. Cystitis, Polypoid and Papillary
209. Mullerianosis
210. Urothelial Papilloma
211. T1 high-grade bladder carcinoma outcome: the role of p16, topoisomerase-IIα, survivin, and E-cadherin
212. The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines
213. Metastatic solid tumours to the penis: a clinicopathologic evaluation of 109 cases from an international collaboration
214. Hyperglycemia and microRNAs in prostate cancer
215. Pathologic abnormalities of placental structure and function in diabetes
216. News in the classification of WHO 2022 bladder tumors
217. Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder
218. Correction to: PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders
219. What's new in WHO fifth edition - urinary tract
220. What's new in WHO fifth edition – urinary tract
221. Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP
222. The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy
223. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*.
224. Unlike in clear cell renal cell carcinoma, KRAS is not mutated in multilocular cystic clear cell renal cell neoplasm of low potential
225. Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors
226. Robotic approach with neoadjuvant chemotherapy in adult Wilms’ tumor: A feasibility study report and a systematic review of the literature
227. Computer-aided diagnosis in prostate cancer: a retrospective evaluation of the Watson Elementary® system for preoperative tumor characterization in patients treated with robot-assisted radical prostatectomy.
228. Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study
229. The role of COVID-19 in prostate tissue inflammation: first pathological evidence
230. Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional Experience
231. Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer
232. Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series
233. Exploring the Diversity and Predictors of Histopathological Findings Across the European Association of Urology Guidelines Office Rapid Reaction Group Priority Groups for Patients with Renal Tumors: Implications for Individualized Prioritization of Renal Cancer Care
234. Genetic mutations in accordance with a low malignant potential tumour are not demonstrated in clear cell papillary renal cell carcinoma
235. Correction to: Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer
236. Histopathological Validation of the Surface-Intermediate-Base Margin Score for Standardized Reporting of Resection Technique during Nephron Sparing Surgery
237. Robot-Assisted Laparoscopic Vesiculectomy for Large Seminal Vesicle Cystadenoma: A Case Report and Review of the Literature
238. Senescent stroma promotes prostate cancer progression: The role of miR-210
239. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
240. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
241. Cyclooxygenase-2: A novel target in human solid tumors
242. Uropathology
243. In situ adenocarcinoma and squamous carcinoma of uterine cervix: Pathological and immunohistochemical analysis with cytokeratin 13
244. A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma
245. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
246. TFE3 Gene Rearrangement in Perivascular Epithelioid Cell Neoplasm (PEComa) of the Genitourinary Tract
247. Impact of the pre-transplant histological score on 3-year graft outcomes of kidneys from marginal donors: a single-centre study
248. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: An investigation using Cdx-2 and a limited immonuhistochemical panel
249. Polypoid Intestinal Metaplasia of the External Urethral Meatus
250. Primitive Testicular Leiomyosarcoma: An Immunohistochemical and Ultrastructural Study with a Review of the Literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.